0001209191-19-057402.txt : 20191120 0001209191-19-057402.hdr.sgml : 20191120 20191120124425 ACCESSION NUMBER: 0001209191-19-057402 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191119 FILED AS OF DATE: 20191120 DATE AS OF CHANGE: 20191120 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RINGO WILLIAM R CENTRAL INDEX KEY: 0001238325 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36070 FILM NUMBER: 191233593 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: FIVE PRIME THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001175505 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 260038620 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 111 OYSTER POINT BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 415-365-5600 MAIL ADDRESS: STREET 1: 111 OYSTER POINT BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: FIVE PRIME THERAPEUTICS INC DATE OF NAME CHANGE: 20020613 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-11-19 0 0001175505 FIVE PRIME THERAPEUTICS, INC. FPRX 0001238325 RINGO WILLIAM R 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 1 1 0 0 Interim CEO Employee Stock Option (right to buy) 3.23 2019-11-19 4 A 0 50367 0.00 A 2029-11-18 Common Stock 50367 50367 D This option will vest in its entirety on December 19, 2019, subject to the reporting person's continued service to Five Prime Therapeutics, Inc. through such vest date. /s/ Francis Sarena, Attorney-in-fact 2019-11-20